Artificial intelligence and treatment levels are the topics of the mini-symposia slated for the 41st annual San Antonio Breast Cancer Symposium (SABCS) Dec. 4-8.
In “Man vs. Machine: Now and in the Future,” panelists will discuss the role artificial intelligence and machine learning has in breast cancer treatment. Panelists in “Over and Under Treatment: The Bookends That Keep Us from Getting It Right for Each Patient,” will explore each end of the treatment spectrum.
Man vs. Machine: Now and in the Future will be moderated by Jenny C. Chang, MD of Houston Memorial Hospital, Houston.
- Alan Karthikesalingam, MD, PhD of DeepMind, London will speak on artificial intelligence for health care.
- Nico Karssemeijer, PhD of Radboud University Medical Centre, Nijmejen, Netherlands will discuss deep learning systems for reading mammograms and breast tomosynthesis.
- Andrew H. Beck, MD, PhD co-founder of PathAI in Cambridge, Massachusetts will cover artificial intelligence to optimize the accuracy and predictability of breast cancer pathology.
Over and Under Treatment: The Bookends That Keep Us from Getting It Right for Each Patient will be moderated by Eric P. Winer, MD of the Dana-Faber Cancer Institute in Boston.
- Reshma Jagsi, MD, DPhil, Director of Center for Bioethics and Social Sciences in Medicine at the University of Michigan, Ann Arbor, Michigan, will discuss overtreatment.
- Rachel A. Freedman, MD, MPH of the Dana-Faber Cancer Institute will cover missed opportunities and the perils of undertreatment.
The mini-symposia will be in Hall 3 of the Henry B. Gonzalez Convention Center. Man vs. Machine will be presented on Thursday, Dec. 6, and Over and Under Treatment will be presented on Friday, Dec. 7. Both mini-symposia will begin at 2:15 p.m.